Skip to main content

Table 1 Clinical recommendations formulated during the ICC-PBM as published previously [2]

From: Adverse events of iron and/or erythropoiesis-stimulating agent therapy in preoperatively anemic elective surgery patients: a systematic review

Clinical recommendation

Strength of recommendation and certainty of evidence

1. Detection and management of preoperative anemia early enough before major elective surgery

Strong recommendation, low-certainty evidence

2. Use of iron supplementation to reduce red blood cell transfusion rate in adult preoperative patients with iron-deficient anemia undergoing elective surgery

Conditional recommendation, moderate-certainty evidence

3. Do not use erythropoiesis-stimulating agents routinely in general for adult preoperative patients with anemia undergoing elective surgery

Conditional recommendation, low-certainty evidence

4. Consider short-acting erythropoietins in addition to iron supplementation to reduce transfusion rates in adult preoperative patients with hemoglobin concentrations < 13 g/dL undergoing elective major orthopedic surgery

Conditional recommendation, low-certainty evidence